An FT investigation has found a thriving market for stem cell therapies in the US promising longer, healthier lives. Experts say such claims are dangerous
Related stories
What do you spend too much on?
Dear culture-war motorists, look to the future. We'll all be driving at 20mph soon | Christian Wolmar
From maligned second city to Insta magnet: Marseille isFrance’s new capital of overtourism
How did Trump get so rich? – podcast
US corporate profits surge to record as worker payouts wilt
Saudi Arabia shakes up flagship real estate project